Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: Possible in vivo regulation via induction of proteases

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2145-2153

  Etoh, T ^a   Inoue, H ^a   Tanaka, S ^a   Barnard, G F ^a   Kitano, S ^a   Mori, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROTEINASE; UROKINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHOSPHORYLATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME INDUCTION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA;

ANGIOPOIETIN-2; ANIMALS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BIOSYNTHESIS; PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035266253     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Angiogenic factors
2. What is the evidence that tumors are angiogenesis dependent?
3. Angiogenesis in cancer, vascular, rheumatoid and other disease
4. Microvessel count predicts metastasis and prognosis in patients with gastric cancer
5. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
6. Clinical prognostic significance of tumour angiogenesis
7. Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma
8. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma
9. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
10. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
11. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
12. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
13. The angiopoietins: Yin and Yang in angiogenesis
14. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors
15. Signaling vascular morphogenesis and maintenance
16. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
17. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
18. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
19. Vascular endothelial growth factor and the angiopoietins: Working together to build a better blood vessel
20. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis
21. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
22. Motility relined protein 1 (MRP1/CD9) expression in colon cancer
23. Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential
24. G-protein γ 7 is down-regulated in cancers and associated with p 27kip1-induced growth arrest
25. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells
26. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer
27. The General Rules for the Gastric Cancer Study
28. Expression of vascular endothelial growth factor and its receptor. KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
29. Intratumoral neovascularization and growth pattern in early gastric carcinoma
30. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis
31. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
32. Matrix metalloproteinases in angiogenesis: Moving target for therapeutic intervention
33. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
34. Matrix metalloproteinases and metastasis
35. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
36. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis
37. Evolution of the ets gene family
38. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
39. Role of ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter
40. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated
41. The ets gene family
42. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia